Table 1.
Relationship between AE2 expression and clinicopathological features of gastric cancer
| Clinicopathological features | No.a | AE2 expression | P value | |
|---|---|---|---|---|
| Negative no. (%) | Positive no. (%) | |||
| Mean ages (years) | ||||
| 63.6 ± 12.8 | 174 | 119 | 55 | |
| Age (years) | 0.6247 | |||
| ≤ 65 | 87 | 61 (70.11) | 26 (29.89) | |
| > 65 | 87 | 58 (66.67) | 29 (33.33) | |
| Gender | 0.4655 | |||
| Male | 107 | 71 (66.36) | 36 (33.64) | |
| Female | 67 | 48 (71.64) | 19 (28.36) | |
| Differentiation | 0.0005 | |||
| Well or Moderately | 72 | 39 (54.17) | 33 (45.83) | |
| Poorly | 101 | 80 (79.21) | 21 (20.79) | |
| Lymph metastasis | 0.7668 | |||
| Negative | 39 | 26 (66.67) | 13 (33.33) | |
| Positive | 133 | 92 (69.17) | 41 (30.83) | |
| TNM staging | 0.0179 | |||
| I | 20 | 9 (45.00) | 11 (55.00) | |
| II–IV | 130 | 93 (71.54) | 37 (28.46) | |
| Lauren classification | 0.0002 | |||
| Intestinal type | 66 | 37 (56.06) | 29 (43.94) | |
| Diffuse type | 82 | 69 (84.15) | 13 (15.85) | |
Values in parenthesis are percentage
aThe data was partially analyzed due to the unparticular information